Literature DB >> 10631957

Dendritic cells, B cells and the regulation of antibody synthesis.

G MacPherson1, N Kushnir, M Wykes.   

Abstract

Dendritic cells (DC) are usually thought of as antigen-presenting cells for T cells. However, recent studies from our laboratory and those of others have shown that they have important roles in B-cell activation and regulation of antibody synthesis. Rat DC make short term interactions with resting B cells and these interactions can be stimulated by cross-linking molecules on either cell surface. These DC can retain antigen in native form for at least 36 h in vivo and in vitro and can subsequently release it for recognition by B cells. In vivo antibody responses induced by antigen-pulsed DC are skewed towards IgG. In vitro, naäive B cells incubated with antigen-pulsed DC subsequently secrete IgM and IgG when cultured with an antigen-specific CD4+ T-cell line, whereas if B cells are incubated with antigen without DC, only IgM is produced. These observations show that DC play an important role in the initiation of and regulation of antibody synthesis.

Entities:  

Mesh:

Year:  1999        PMID: 10631957     DOI: 10.1111/j.1600-065x.1999.tb01376.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  29 in total

1.  Antitumor activities of human dendritic cells derived from peripheral and cord blood.

Authors:  Jin-Kun Zhang; Jun Li; Hai-Bin Chen; Jin-Lun Sun; Yao-Juan Qu; Juan-Juan Lu
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 2.  B cell follicles and antigen encounters of the third kind.

Authors:  Jason G Cyster
Journal:  Nat Immunol       Date:  2010-10-19       Impact factor: 25.606

Review 3.  Immunoregulation of dendritic cells.

Authors:  Mark A Wallet; Pradip Sen; Roland Tisch
Journal:  Clin Med Res       Date:  2005-08

4.  Morphological interactions of interdigitating dendritic cells with B and T cells in human mesenteric lymph nodes.

Authors:  K Takahashi; A Kenji; T Norihiro; K Eisaku; O Takashi; H Kazuhiko; Y Tadashi; A Tadaatsu
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

5.  Dendritic cells interacting mainly with B cells in the lymphoepithelial symbiosis of the human palatine tonsil.

Authors:  Kiyoshi Takahashi; Yuriko Nishikawa; Hiaki Sato; Takashi Oka; Tadashi Yoshino; Katsuya Miyatani
Journal:  Virchows Arch       Date:  2006-03-08       Impact factor: 4.064

6.  IFN-α produced by human plasmacytoid dendritic cells enhances T cell-dependent naïve B cell differentiation.

Authors:  Cornelia Gujer; Kerrie J Sandgren; Iyadh Douagi; William C Adams; Christopher Sundling; Anna Smed-Sörensen; Robert A Seder; Gunilla B Karlsson Hedestam; Karin Loré
Journal:  J Leukoc Biol       Date:  2011-01-13       Impact factor: 4.962

7.  Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis.

Authors:  Y-Z Wang; F-F Tian; M Yan; J-M Zhang; Q Liu; J-Y Lu; W-B Zhou; H Yang; J Li
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

8.  Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.

Authors:  Matthew N Meriggioli; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

9.  Display of Native Antigen on cDC1 That Have Spatial Access to Both T and B Cells Underlies Efficient Humoral Vaccination.

Authors:  Yu Kato; Thiago M Steiner; Hae-Young Park; Rohan O Hitchcock; Ali Zaid; Jyh Liang Hor; Sapna Devi; Gayle M Davey; David Vremec; Kirsteen M Tullett; Peck S Tan; Fatma Ahmet; Scott N Mueller; Sylvie Alonso; David M Tarlinton; Hidde L Ploegh; Tsuneyasu Kaisho; Lynette Beattie; Jonathan H Manton; Daniel Fernandez-Ruiz; Ken Shortman; Mireille H Lahoud; William R Heath; Irina Caminschi
Journal:  J Immunol       Date:  2020-08-24       Impact factor: 5.422

10.  Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus.

Authors:  Stephen H Clarke
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.